Bioinformatics of Non Small Cell Lung Cancer and the Ras Proto-Oncogene

Cancer is initiated by activation of oncogenes or inactivation of tumor suppressor genes. Mutations in the K-ras proto-oncogene are responsible for 10–30% of adenocarcinomas. Clinical Findings point to a wide variety of other cancers contributing to lung cancer incidence. Such a scenario makes ident...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Kashyap, Amita (Συγγραφέας), Bujamma, D. (Συγγραφέας), Babu M, Naresh (Συγγραφέας)
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Singapore : Springer Singapore : Imprint: Springer, 2015.
Σειρά:SpringerBriefs in Applied Sciences and Technology,
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03263nam a22005895i 4500
001 978-981-4585-08-8
003 DE-He213
005 20151103130709.0
007 cr nn 008mamaa
008 140908s2015 si | s |||| 0|eng d
020 |a 9789814585088  |9 978-981-4585-08-8 
024 7 |a 10.1007/978-981-4585-08-8  |2 doi 
040 |d GrThAP 
050 4 |a Q342 
072 7 |a UYQ  |2 bicssc 
072 7 |a COM004000  |2 bisacsh 
082 0 4 |a 006.3  |2 23 
100 1 |a Kashyap, Amita.  |e author. 
245 1 0 |a Bioinformatics of Non Small Cell Lung Cancer and the Ras Proto-Oncogene  |h [electronic resource] /  |c by Amita Kashyap, D. Bujamma, Naresh Babu M. 
264 1 |a Singapore :  |b Springer Singapore :  |b Imprint: Springer,  |c 2015. 
300 |a VII, 72 p. 40 illus., 39 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a SpringerBriefs in Applied Sciences and Technology,  |x 2191-530X 
505 0 |a Introduction -- Review of Literature -- Materials and Methods (Tools and Databases) -- Flowchart -- Conclusion.-References. 
520 |a Cancer is initiated by activation of oncogenes or inactivation of tumor suppressor genes. Mutations in the K-ras proto-oncogene are responsible for 10–30% of adenocarcinomas. Clinical Findings point to a wide variety of other cancers contributing to lung cancer incidence. Such a scenario makes identification of lung cancer difficult and thus identifying its mechanisms can contribute to the society. Identifying unique conserved patterns common to contributing proto-oncogenes may further be a boon to Pharmacogenomics and pharmacoinformatics. This calls for ab initio/de novo drug discovery that in turn will require a comprehensive in silico approach of Sequence, Domain, Phylogenetic and Structural analysis of the receptors, ligand screening and optimization and detailed Docking studies. This brief involves extensive role of the RAS subfamily that includes a set of proteins, which cause an over expression of cancer-causing genes like M-ras and initiate tumour formation in lungs. SNP Studies and Structure based drug discovery will also be undertaken. 
650 0 |a Engineering. 
650 0 |a Cancer research. 
650 0 |a Health informatics. 
650 0 |a Bioinformatics. 
650 0 |a Applied mathematics. 
650 0 |a Engineering mathematics. 
650 0 |a Computational intelligence. 
650 0 |a Biomedical engineering. 
650 1 4 |a Engineering. 
650 2 4 |a Computational Intelligence. 
650 2 4 |a Computational Biology/Bioinformatics. 
650 2 4 |a Cancer Research. 
650 2 4 |a Biomedical Engineering. 
650 2 4 |a Health Informatics. 
650 2 4 |a Appl.Mathematics/Computational Methods of Engineering. 
700 1 |a Bujamma, D.  |e author. 
700 1 |a Babu M, Naresh.  |e author. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9789814585071 
830 0 |a SpringerBriefs in Applied Sciences and Technology,  |x 2191-530X 
856 4 0 |u http://dx.doi.org/10.1007/978-981-4585-08-8  |z Full Text via HEAL-Link 
912 |a ZDB-2-ENG 
950 |a Engineering (Springer-11647)